Aladdin Blockchain Technologies Holding SE

  • WKN: A12ULL
  • ISIN: DE000A12ULL2
  • Land: Deutschland

Nachricht vom 13.06.2018 | 12:26

Aladdin Blockchain Technologies Holding SE: Aladdin enters into commercial agreement with OurHealthMate, India

Aladdin Blockchain Technologies Holding SE / Key word(s): Agreement
Aladdin Blockchain Technologies Holding SE: Aladdin enters into commercial agreement with OurHealthMate, India

13-Jun-2018 / 12:26 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Aladdin enters into a commercial agreement with OurHealthMate, India
Today Aladdin Blockchain Technologies Ltd, London ("Aladdin Ltd") the 100% subsidiary of Aladdin Blockchain Technologies Holding SE ("Aladdin") has entered into a commercial agreement with OurHealthMate India ("OurHealthMate").
OurHealthMate is India's largest healthcare marketplace which is partnered with 30,000 doctors in India. Today, OurHealthMate offers more than 250,000 medical services at fixed cost through their platform offered by more than 2,000 healthcare centres in India, including the majority of the nation's largest hospital chains. All these healthcare centres are partnered with OurHealthMate.
They have reached over 400,000 transactions through their platform. OurHealthMate is recognised by clinicians of the Indian Medical Council and ensure that they only work with and provide appointments with accredited healthcare providers.
Aladdin Ltd and OurHealthMate will work together to create a new healthcare ecosystem within the Indian healthcare market. The agreement stipulates that Aladdin Ltd will establish a Big Data Platform for the medical records of Indian patients.
The agreement solidifies that Aladdin Ltd can diversify its consumer base into other substantial global markets.
Through the agreement, Aladdin Ltd will securely be able to analyse significant amounts of data, via the OurHealthMate platform. By H2 2018 OurHealthMate and Aladdin Ltd will begin the Phase 1 which will be establishing a Big data platform that has the capability of analysing more than 12 million data points.
The agreement states that Aladdin Ltd and OurHealthMate will work together to facilitate data asset creation within the Indian market starting with 500,000 medical records in H2 2018, rising up to 5 million medical records on the Big Data Platform by end of 2020.
Through this partnership, Aladdin Blockchain Technologies will be utilizing its artificial intelligence (AI) and machine learning (ML) expertise to build a stronger and more secure healthcare platform - enabling the early detection and prevention of chronic diseases within India. Aiming at significant cost savings in the healthcare market, this marketable technology is intended to create substantial value for various stakeholders in the healthcare ecosystem.
The agreement states that Aladdin Ltd will design a future use-case of a Blockchain solution for the Indian healthcare market and the partners will collaborate with hospitals, insurers, pharmaceutical companies and other healthcare institutions in India with the intention of revolutionizing and significantly expanding healthcare ecosystem.
Wade Menpes-Smith, CEO

Aladdin Blockchain Technologies Holding SE, Unter den Linden 10, 10117 Berlin, Tel 030/700 140 449, Fax 030/700 140 150, email:,

13-Jun-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

Aves One AG: kursziel deutlich angehoben

Die Aves One AG ist im Geschäftsjahr 2017 abermals dynamisch gewachsen. Der Umsatz stieg um fast 90 % auf über 53 Mio. EUR an. Der jetzt gemeldete Erwerb von umfangreichen Rail-Assets (VTG/Nacco-Deal) soll zu weiteren Steigerungen beitragen. Wir erwarten weiteres Wachstum von über 40% im laufenden Jahr sowie einen dynamischen Anstieg in den Folgejahren. Das Ziel von 1 Mrd. Assets und Managment könnte bereits 2019 und damit ein Jahr früher erreicht werden. Unsere Analysten sind vom VTG/Nacco-Deal überzeugt und haben das Kursziel deutlich auf 12,10 Euro erhöht (bisher 9,10 Euro).

Aktueller Webcast

EQS Group AG

Half-yearly financial statements 2018

16. August 2018

Aktuelle Research-Studie

SMT Scharf AG

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

15. August 2018